Literature DB >> 8023028

Time series for modelling counts from a relapsing-remitting disease: application to modelling disease activity in multiple sclerosis.

P S Albert1, H F McFarland, M E Smith, J A Frank.   

Abstract

Many chronic diseases are relapsing-remitting diseases, in which subjects alternate between periods with increasing and decreasing disease activity; relapsing-remitting multiple sclerosis is an example. This paper proposes two classes of models for sequences of counts observed from a relapsing-remitting disease. In the first, the relapsing-remitting nature of the data is modelled by a Poisson time series with a periodic trend in the mean. In this approach, the mean is expressed as a function of a sinusoidal trend and past observations of the time series. An algorithm that uses GLIM is developed, and it results in maximum-likelihood estimation for the amplitude, frequency and autoregressive effects. In the second class of models, the relapsing-remitting behaviour is described by a Poisson time series in which changes in the mean follow a latent Markov chain. An EM algorithm is developed for maximum-likelihood estimation for this model. The two models are illustrated and compared with data from a study evaluating the use of serial magnetic resonance imaging as a measure of disease activity in relapsing-remitting multiple sclerosis.

Entities:  

Mesh:

Year:  1994        PMID: 8023028     DOI: 10.1002/sim.4780130509

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Bayesian hidden Markov models for delineating the pathology of Alzheimer's disease.

Authors:  Kai Kang; Jingheng Cai; Xinyuan Song; Hongtu Zhu
Journal:  Stat Methods Med Res       Date:  2017-12-26       Impact factor: 3.021

2.  Exposure-disease response analysis of natalizumab in subjects with multiple sclerosis.

Authors:  Kumar Kandadi Muralidharan; Deb Steiner; Diogo Amarante; Pei-Ran Ho; Dan Mikol; Jacob Elkins; Meena Subramanyam; Ivan Nestorov
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-03-01       Impact factor: 2.745

3.  Examination of the role of magnetic resonance imaging in multiple sclerosis: A problem-orientated approach.

Authors:  Henry F McFarland
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

4.  Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients.

Authors:  Yaming Hang; Xiao Hu; Jie Zhang; Shifang Liu; Aaron Deykin; Ivan Nestorov
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-06-14       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.